FDA Investigator Linh Tu
Linh Tu has conducted inspections on 26 sites in 2 countries as of 13 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
26
Last Inspection Date:
13 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Switzerland
FDA Investigators that have inspected at least one site in common with Linh Tu:
Adam S Freeman,
Althea A Williams,
Andrea A Branche,
Andrea George, PhD,
Angel K Sandhu,
Anh M Lac,
Barbara J Wilcox, PhD,
Calvin B Koerner,
Carl Lee,
Carole L Jones,
CDR Rochelle B Young, RPh, MSA,
Christine M Parmentier,
Christopher R Czajka,
Cynthia J Tsui,
Daniel J Roberts,
Dr. Mark J Seaton, PhD,
Dr. Ralph M Bernstein, PhD,
Dustin P Tran,
Dustin R Abaonza,
Emily Shacter,
Eric L Dong, BS,
Eric W Anderson,
Francis J Eng,
Gerald Feldman,
Gerald M Feldman, PhD,
Gloria J Baca, MS,
Henry K Lau,
Humberto Z Gomez,
James A Lane,
James R Evans,
Jeanne Fringer, PhD,
Jeanne J Thai,
Jeffrey M Watson,
Jeffrey W Shrifter, DPM,
Joan T Briones,
Joey V Quitania,
Joseph A Seitz, III,
Joseph Kutze, PhD,
Joseph P Iser, MD,
Joshua S Hunt,
Kevin P Foley,
Kristin M Abaonza,
Lakisha M Williams,
Lance Mde Souza, MBA,
Laurie P Norwood,
Laverne Puckett,
LCDR Jennifer H Rhyu,
Linda Linh N Adams,
Mabel M Lee,
Maida Henesian (NMI),
Maria Pkelly Doggett, MBA,
Marie K Kinkade,
Mariza M Jafary,
Mark W Babbitt,
Marsha W Major,
Mary R Hole,
Michael Shanks, MS,
Michael T Cyrus,
Michelle Rfrazier Jessen, PhD,
Mihaly S Ligmond,
Min Shanmabel Liu,
Nayan J Patel,
Nicholas L Hunt,
Nicholas Obiri, PhD,
Omotunde O Osunsanmi,
Peter E Baker,
Peter Kessler, PhD,
Quynh H Strandberg,
Raymond T Oji,
Rebecca Rodriguez,
Rebecca T Davis,
Riley C Myers, PhD,
Robert D Tollefsen,
Sandra S Saniga,
Scott N Lim,
Serge L Beaucage,
Sheilyn H Huang,
Shelley H Beausoleil,
Sherri J Jackson,
Sherri N Rohlf, MD,
Sidney B Priesmeyer,
Stephanie A Slater, MS,
Stuart W Russell,
Thea C Grome,
Thuy T Nguyen, LCDR,
Timothy C Grome,
Truong Xuan Nguyen (Andy),
Walden H Lee,
William V Millar,
Yi Wang, PhD
Linh Tu's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2022 | FDA 483 | Nicola P. Klein, M.D. - Form 483, 2022-01-03 |
November, 2023 | FDA 483 | Douglas Glenn Young, M.D. - Form 483, 2023-11-20 |
January, 2022 | FDA 483 | Elaine E. Tseng, M.D. - Form 483, 2022-01-28 |
January, 2022 | EIR | Nicola P. Klein, M.D. - EIR, 2022-01-03 |
December, 2023 | FDA 483 | Bay Area Tumor Institute IRB - Form 483, 2023-12-14 |
October, 2021 | FDA 483 | Leila Chaychi, M.D. - Form 483, 2021-10-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more